Dallah Healthcare Company 4004.SR Stock
Dallah Healthcare Company Price Chart
Dallah Healthcare Company 4004.SR Financial and Trading Overview
| Dallah Healthcare Company stock price | 172.2 SAR |
| Previous Close | 170 SAR |
| Open | 170 SAR |
| Bid | 173.4 SAR x N/A |
| Ask | 166.4 SAR x N/A |
| Day's Range | 165.6 - 173 SAR |
| 52 Week Range | 103.8 - 176.8 SAR |
| Volume | 382.23K SAR |
| Avg. Volume | 725 SAR |
| Market Cap | 16.18B SAR |
| Beta (5Y Monthly) | 0.174657 |
| PE Ratio (TTM) | 53.247593 |
| EPS (TTM) | 3.71 SAR |
| Forward Dividend & Yield | 4 (2.35%) |
| Ex-Dividend Date | December 21, 2022 |
| 1y Target Est | 141.7 SAR |
4004.SR Valuation Measures
| Enterprise Value | 18.62B SAR |
| Trailing P/E | 53.247593 |
| Forward P/E | 33.934425 |
| PEG Ratio (5 yr expected) | 4.59 |
| Price/Sales (ttm) | 6.232989 |
| Price/Book (mrq) | 5.169992 |
| Enterprise Value/Revenue | 7.174 |
| Enterprise Value/EBITDA | 34.593 |
Trading Information
Dallah Healthcare Company Stock Price History
| Beta (5Y Monthly) | 0.174657 |
| 52-Week Change | 52.48% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 176.8 SAR |
| 52 Week Low | 103.8 SAR |
| 50-Day Moving Average | 164.49 SAR |
| 200-Day Moving Average | 152.34 SAR |
4004.SR Share Statistics
| Avg. Volume (3 month) | 725 SAR |
| Avg. Daily Volume (10-Days) | 1.8K SAR |
| Shares Outstanding | 97.68M |
| Float | 41.01M |
| Short Ratio | N/A |
| % Held by Insiders | 57.98% |
| % Held by Institutions | 11.84% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 2 |
| Trailing Annual Dividend Yield | 1.17% |
| 5 Year Average Dividend Yield | 235.00% |
| Payout Ratio | 0.64309996 |
| Last Split Factor | 6:5 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 11.03% |
| Operating Margin (ttm) | 17.00% |
| Gross Margin | 35.20% |
| EBITDA Margin | 20.73% |
Management Effectiveness
| Return on Assets (ttm) | 5.11% |
| Return on Equity (ttm) | 11.15% |
Income Statement
| Revenue (ttm) | 2.6B SAR |
| Revenue Per Share (ttm) | 28.34 SAR |
| Quarterly Revenue Growth (yoy) | 17.59% |
| Gross Profit (ttm) | 878.49M SAR |
| EBITDA | 538.21M SAR |
| Net Income Avi to Common (ttm) | 286.49M SAR |
| Diluted EPS (ttm) | 3.11 |
| Quarterly Earnings Growth (yoy) | 14.59% |
Balance Sheet
| Total Cash (mrq) | 178.39M SAR |
| Total Cash Per Share (mrq) | 1.83 SAR |
| Total Debt (mrq) | 1.94B SAR |
| Total Debt/Equity (mrq) | 57.47 SAR |
| Current Ratio (mrq) | 1.481 |
| Book Value Per Share (mrq) | 32.031 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 518.6M SAR |
| Levered Free Cash Flow (ttm) | 164.11M SAR |
Profile of Dallah Healthcare Company
| Country | Suriname |
| State | N/A |
| City | Riyadh |
| Address | King Fahed Road |
| ZIP | 12381 |
| Phone | 966 11 2255065 |
| Website | https://www.dallahhealth.com |
| Industry | Medical Care Facilities |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Dallah Healthcare Company operates as a health care company in the Kingdom of Saudi Arabia. The company engages in operating, managing, equipping, and developing hospitals and healthcare facilities, and medical polyclinics; and the provision of manpower and support services to hospitals and medical centers. It also manufactures and distributes pharmaceutical, herbal and cosmetic products to retail pharmacies, health and beauty stores, hospitals, and governmental agencies. In addition, the company engages in the management and operation of hospitals owned by third parties. Further, it manages private hospitals, medical and diagnostic centers, and an analytical laboratory; and provides medical services. The company was formerly known as Dallah Healthcare Holding Company and changed its name to Dallah Healthcare Company in November 2016. The company was incorporated in 1994 and is based in Riyadh, Saudi Arabia. Dallah Healthcare Company is the subsidiary of Dallah Al-Barakah Holding.
Q&A For Dallah Healthcare Company Stock
What is a current 4004.SR stock price?
Dallah Healthcare Company 4004.SR stock price today per share is 172.2 SAR.
How to purchase Dallah Healthcare Company stock?
You can buy 4004.SR shares on the Saudi exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Dallah Healthcare Company?
The stock symbol or ticker of Dallah Healthcare Company is 4004.SR.
Which industry does the Dallah Healthcare Company company belong to?
The Dallah Healthcare Company industry is Medical Care Facilities.
How many shares does Dallah Healthcare Company have in circulation?
The max supply of Dallah Healthcare Company shares is 97.68M.
What is Dallah Healthcare Company Price to Earnings Ratio (PE Ratio)?
Dallah Healthcare Company PE Ratio is 46.41509200 now.
What was Dallah Healthcare Company earnings per share over the trailing 12 months (TTM)?
Dallah Healthcare Company EPS is 3.71 SAR over the trailing 12 months.
Which sector does the Dallah Healthcare Company company belong to?
The Dallah Healthcare Company sector is Healthcare.